Bayer AG (Symbol:BAYN) SWOT Analysis, Strategy, Revenues and Profits

• Publication date: April 2013
• Report size: 72 pages

Bayer AG (Bayer) engages in the development, production, and marketing of health care, nutrition and high-tech materials. Operating as the management holding company for the Bayer Group, the company’s business operations are classified into three subgroups, namely Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. Operating through 350 companies worldwide, the company markets about 5,000 products, to benefit people and impro...

Bayer AG (Bayer) engages in the development, production, and marketing of health care, nutrition and high-tech materials. Operating as the management holding company for the Bayer Group, the company’s business operations are classified into three subgroups, namely Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. Operating through 350 companies worldwide, the company markets about 5,000 products, to benefit people and improve their quality of life. Major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. Bayer and its subsidiaries have operations in Europe, North America, Latin America, Asia Pacific, Africa, and the Middle East. Recently, the company amended its existing collaboration with Mendel Biotechnology, Inc., by entering into a new three-year collaboration agreement, for higher yields and improved stress tolerance in crops. Also, the company, through Bayer MaterialScience, formed technical collaboration with Mitsubishi Heavy Industries Plastic Technology Co., Ltd. and Kyowa Industrial Co., Ltd., for the use of PC glazing in the Japanese automotive industry. Additionally, in recent dates, Ehrfeld Mikrotechnik BTS, a Bayer Technology Services company, inked a worldwide manufacturing and distribution license agreement with Lonza, to exclusively manufacture and market Lonza microreactors; and Bayer MaterialScience inked a strategic partnership agreement with Masdar, a wholly-owned subsidiary of the Mubadala Development Company, for the proposed construction of an EcoCommercial Building prototype in Masdar City, Abu Dhabi. The company is headquartered in Leverkusen, Germany

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

Bayer AG SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about Bayer AG operations to identify potential customers, partners and suppliers. Bayer AG business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Latest Company Developments:

Global Chemical Industry

I - Bayer AG Company Profile

Key Information
Overview
Key Employees and biographies
Operational Heads
Main Products and Services
Historical Data
Company Mission Statement
Operations And Subsidiaries
Headquarter

II - Bayer AG Company Analysis

Business Description
Company Vision and Strategy
SWOT Analysis
Strengths, Weaknesses, Opportunities, Threats
Competitive Landscape

III - Bayer AG Financial Analysis and Performance Charts

Financial Ratios
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios